Cefixime + Ofloxacin in pharma franchise in Sikkim

Cefixime + Ofloxacin in PCD pharma franchise in Aurangabad

Cefixime + Ofloxacin in top pharma company in Udaipur

Cefixime + Ofloxacin in pcd pharma supplier in Bardhaman

Cefixime + Ofloxacin in phama franchise company in India
Cefixime + Ofloxacin in phama distributor in Bharuch

Home/Products /cefixime-200mg-ofloxacin-200mg-tablet

Cefzlan O Tablet

Composition : Cefixime (200mg) + Ofloxacin (200mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹206/-

Cefzlan O Tablet combines two potent antibiotics, cefixime and ofloxacin, each at a dosage of 200 mg. This dual-action formulation is designed to effectively combat a range of bacterial infections. Cefixime, a cephalosporin antibiotic, works by disrupting the formation of bacterial cell walls, leading to cell lysis and death. Ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV, crucial enzymes for DNA replication and repair. Together, these components target both Gram-positive and Gram-negative bacteria, making Cefzlan O particularly useful in treating respiratory tract infections, urinary tract infections, and certain skin infections.

Patients should be aware that while Cefzlan O is effective against various bacterial strains, it is essential to use this medication as prescribed by a healthcare professional. Misuse or overuse of antibiotics can lead to antibiotic resistance, making infections harder to treat. It is important to complete the full course of the medication, even if symptoms improve before finishing the treatment.

Read More

About the Product

Cefzlan O Tablet combines two potent antibiotics, cefixime and ofloxacin, each at a dosage of 200 mg. This dual-action formulation is designed to effectively combat a range of bacterial infections. Cefixime, a cephalosporin antibiotic, works by disrupting the formation of bacterial cell walls, leading to cell lysis and death. Ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV, crucial enzymes for DNA replication and repair. Together, these components target both Gram-positive and Gram-negative bacteria, making Cefzlan O particularly useful in treating respiratory tract infections, urinary tract infections, and certain skin infections.

Patients should be aware that while Cefzlan O is effective against various bacterial strains, it is essential to use this medication as prescribed by a healthcare professional. Misuse or overuse of antibiotics can lead to antibiotic resistance, making infections harder to treat. It is important to complete the full course of the medication, even if symptoms improve before finishing the treatment.

Common side effects may include nausea, diarrhea, dizziness, and abdominal pain. Serious side effects, although rare, can include allergic reactions and tendon damage.

Cefzlan O is indicated for the treatment of infections caused by susceptible strains of bacteria, including respiratory, urinary, and skin infections.

Consult a healthcare provider before use if you have a history of allergies to antibiotics, are pregnant or breastfeeding, or are taking other medications to avoid potential interactions. In summary, Cefzlan O Tablet is a powerful option for treating various bacterial infections. Its unique combination of cefixime and ofloxacin enhances its efficacy, ensuring patients receive comprehensive care against infections. Always follow your healthcare provider’s instructions and report any unusual symptoms or side effects during treatment.

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation